Perrigo Q3 Earnings Beat, Sales Miss, Stock Falls on '25 View Cut — Neutral
PRGO Zacks Investment Research — November 05, 2025PRGO beats Q3 earnings estimates but misses on sales. It also trims the 2025 outlook and launches a strategic review of its infant formula unit.
Axon Enterprise Shares Jump Over 12% After Key Trading Signal — Positive
AXON Benzinga — November 05, 2025Axon Enterprise Inc (NASDAQ:AXON) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data.At 10:28 AM EST on November 5, AXON triggered a Power Inflow signal at a price of $584.93. In the hour leading up to the Power Inflow signal, AXON's stock price had some slight pullback following the initial price rise that occurred earlier in the day.
Tevogen Reports Major Clinical Milestone: Expands HLA Coverage of its Investigational Precision T Cell Therapy for Acute and Long COVID — Neutral
TVGN GlobeNewsWire — November 05, 2025WARREN, N.J., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today announced a clinical milestone in the evolution of its proprietary ExacTcell™ platform: completion of T cell target identification for an additional five human leukocyte antigen (HLA) restrictions. This advancement significantly broadens the accessibility of Tevogen's investigational precision T cell therapies by extending therapeutic reach beyond the single HLA-A*02:01 restriction used in the Company's initial proof-of-concept (POC) clinical trial, the results of which were published in Blood Advances . That study demonstrated the safety and feasibility of Tevogen's third-party cytotoxic T lymphocyte …
VERSANT to Host Inaugural Investor Day on December 4, 2025 — Neutral
CMCSA Business Wire — November 05, 2025NEW YORK--(BUSINESS WIRE)--Comcast Corporation and VERSANT, Comcast's planned spin-off of select media brands and digital businesses, today announced that VERSANT will host its inaugural Investor Day on Thursday, December 4 in New York City. The event will be webcast live on www.CMCSA.com and will feature presentations from VERSANT's Chief Executive Officer Mark Lazarus, Chief Operating Officer and Chief Financial Officer Anand Kini, and members of VERSANT's senior leadership team. Upon complet.
Fiverr: Restructuring Will Unlock Substantial EBITDA Expansion, Risks Remain — Positive
FVRR Seeking Alpha — November 05, 2025Fiverr remains a "Buy" as it delivers double-digit revenue growth, driven by surging demand for AI-related freelance jobs and internal AI adoption. Fiverr boosted its FY25 adjusted EBITDA expectations, yet shares remain undervalued at single-digit EBITDA multiples. Pay attention to Fiverr's expansion into enterprise deals, new hourly contract options, and a restructuring plan focused on AI efficiency and tech upgrades.
DuPont de Nemours NYSE: DD has officially reshaped its future, completing the spinoff of its high-tech electronics division into a new, publicly traded entity: Qnity Electronics NYSE: Q.
Why this critical Google business may be seriously underestimated on Wall Street — Positive
GOOG GOOGL Market Watch — November 05, 2025Wall Street sees Google Cloud growing at 31% in 2026 — but one analyst is modeling a path to 50%.
UPS Plane That Crashed Was 34 Years Old—and Repaired in September — Negative
UPS WSJ — November 05, 2025The MD-11 is an old workhorse for FedEx and UPS that has been getting phased out.
Axsome: Alzheimer's Disease Agitation sNDA Adds Optionality, Not A Thesis Changer — Positive
AXSM Seeking Alpha — November 05, 2025Axsome Therapeutics remains a 'Sell' due to an undifferentiated CNS pipeline, heavy SG&A, and ongoing net losses despite revenue growth. Auvelity's sales growth appears largely marketing-driven and competes in a crowded, generic-heavy depression market. AXS-05 for Alzheimer's agitation offers some promise as a non-antipsychotic, but real-world adoption and blockbuster potential are limited.
ETF Prime: Balchunas on Crypto ETFs, Leveraged Products — Neutral
CAIE ETF Trends — November 05, 2025On this week's episode of ETF Prime, Eric Balchunas, Bloomberg Intelligence senior ETF analyst, joins host Nate Geraci to discuss the most fascinating developments in the ETF industry, from the explosive success of crypto ETFs to the emerging “hot sauce arms race” in leveraged products.
Novo Nordisk A/S delivered mixed Q3 '25 results, with modest revenue growth but a 27% drop in net profit due to higher financing costs. NVO's GLP-1 franchise, led by Ozempic and Wegovy, faces moderated growth and supply constraints, yet remains a key revenue driver at 49% of sales. Promising Phase 3 data for oral Wegovy supports its potential as the first oral GLP-1 obesity therapy, with an FDA decision expected by end-2025.
Utility Stock Pops Before Third-Quarter Report — Positive
SMR Schaeffers Research — November 05, 2025Utilities name NuScale Power Corp (NYSE:SMR) is charging higher this afternoon, up 6.6% at $38.01, at last check, as investors prepare for the company's third-quarter report, due out after the close tomorrow.
Arvinas, Inc. (ARVN) Q3 2025 Earnings Call Transcript — Neutral
ARVN Seeking Alpha — November 05, 2025Arvinas, Inc. ( ARVN ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Jeff Boyle - Vice President of Investor Relations John Houston - Chairperson, CEO & President Noah Berkowitz - Chief Medical Officer Angela Cacace - Chief Scientific Officer Andrew Saik - CFO & Treasurer Conference Call Participants Etzer Darout - Barclays Bank PLC, Research Division Jeet Mukherjee - BTIG, LLC, Research Division Li Wang Watsek - Cantor Fitzgerald & Co., Research Division Srikripa Devarakonda - Truist Securities, Inc., Research Division Tazeen Ahmad - BofA Securities, Research Division Kyuwon Choi - Goldman Sachs Group, Inc., …
Alight, Inc. (ALIT) Q3 2025 Earnings Call Transcript — Neutral
ALIT Seeking Alpha — November 05, 2025Alight, Inc. ( ALIT ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Jeremy Cohen - Vice President of Investor Relations David Guilmette - CEO & Vice Chair of the Board Jeremy Heaton - Chief Financial Officer Conference Call Participants Kyle Peterson - Needham & Company, LLC, Research Division Scott Schoenhaus Kevin McVeigh - UBS Investment Bank, Research Division Peter Heckmann - D.A. Davidson & Co., Research Division Andrew Polkowitz - JPMorgan Chase & Co, Research Division Presentation Operator Good morning, and thank you for holding.
Sachem Capital Corp. (SACH) Q3 2025 Earnings Call Transcript — Neutral
SACH Seeking Alpha — November 05, 2025Sachem Capital Corp. ( SACH ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants John Villano - Founder, Chairman, President & CEO Jeffery Walraven - Executive VP & CFO Conference Call Participants Christopher Nolan - Ladenburg Thalmann & Co. Inc., Research Division Gaurav Mehta - Alliance Global Partners, Research Division Presentation Operator Greetings, and welcome to the Sachem Capital Corp. Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
Is the Options Market Predicting a Spike in Korn Ferry Stock? — Neutral
KFY Zacks Investment Research — November 05, 2025Investors need to pay close attention to KFY stock based on the movements in the options market lately.
4 Low-PEG Value Stocks That Could Deliver Market-Beating Returns — Positive
FLEX FOX GTX SUZ Zacks Investment Research — November 05, 2025These four low-PEG picks - Fox, Flex, Suzano, and Garrett Motion - show strong growth potential and may deliver market-beating returns.
History suggests gold has yet to peak, inflation could drive the next leg up – AJ Bell's Mould — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL UGL Kitco — November 05, 2025Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.
Western Midstream Partners, LP Common Units (WES) Q3 2025 Earnings Call Transcript — Neutral
WES Seeking Alpha — November 05, 2025Western Midstream Partners, LP Common Units ( WES ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Daniel Jenkins - Director of Investor Relations - Western Midstream Holdings LLC Oscar Brown - President, CEO & Director - Western Midstream Holdings LLC Daniel Holderman - Senior VP & COO of Western Midstream Holdings, LLC Kristen Shults - Senior VP & CFO - Western Midstream Holdings LLC Conference Call Participants Keith Stanley - Wolfe Research, LLC Gabriel Moreen - Mizuho Securities USA LLC, Research Division Jeremy Tonet - JPMorgan Chase & Co, Research Division Spiro Dounis - Citigroup …
Lemonade, Inc. (LMND) Q3 2025 Earnings Call Transcript — Neutral
LMND Seeking Alpha — November 05, 2025Lemonade, Inc. ( LMND ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Daniel Schreiber - CO-Founder, Chairman & CEO Shai Wininger - Co-Founder, President & Director Timothy Bixby - CFO, Principal Accounting Officer & Treasurer Conference Call Participants Thomas Mcjoynt-Griffith - Keefe, Bruyette, & Woods, Inc., Research Division Jason Helfstein - Oppenheimer & Co. Inc., Research Division Katie Sakys Zachary Gunn - Financial Technology Partners LP Andrew Andersen - Jefferies LLC, Research Division Presentation Operator Good morning, and thank you all for attending the Lemonade Q3 2025 Earnings Call. My name is Brika, and I'll …